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SuMMary The incidence of cutaneous melanoma has increased significantly 
worldwide over the last several decades. The aim of this study is to determine 
clinical and morphology characteristics of primary melanoma, since some of 
them are important prognostic factors. This retrospective study included 172 pa-
tients. The data were collected by the Consulting team for malignant skin tumors 
in the Banja Luka Clinical Centre from 2009 to 2011. We did not use dermoscopy 
as a diagnostic tool in our investigation. We determined that melanoma occurs 
equally commonly in both sexes, in women in the sixth decade and the seventh 
in men. The most common sub-type was nodular melanoma (59.5%, P<0.05), fol-
lowed by superficial spreading (27.8%) and acral lentiginous melanoma (11.4%). 
The most common localization was on the back in men (34.3%) and on the legs 
in women (P<0.05). More than half of our patients (55.8%) had melanoma thick-
ness from 1.0 to 4.0 mm, and 38% had a melanoma thicker than 4.0 mm. The 
average Breslow thickness is 4.6 mm. More women than men had melanoma 
thicker than 4 mm (P<0.05). Spread of the primary tumor localization was found 
in 31.4% of patients, more frequently in men than in women (P<0.05). In most 
cases it was abstraction of lymph nodes (P<0.05). The average thickness of the 
melanoma in our patients is much higher than the average in the world and the 
countries of Europe. The results of this study indicate a need for better unique 
regional registry in this part of Bosnia and Herzegovina and improvement of pre-
ventive measures in the early diagnosis of melanoma. 
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IntroduCtIon
The incidence of cutaneous melanoma has in-
creased significantly worldwide over the last several 
decades (1). The incidence rates are highest in Aus-
tralia/New Zealand and lowest in South-Central Asia 
with a lot of variations of incidence rates between 
the regions of the world for males and females. The 
incidence of melanoma varies widely within Europe 
from the highest rate in Switzerland, Sweden, and 
Denmark to the lowest of in Romania and Greece 
(2,3). Melanoma in South-East Europe shows varying 
incidence (cases per 100 000 residents) from 1.7 in Al-
bania to 14.5 in Slovenia, but more detailed data from 
this region are scarce (4). Both genetic and environ-
mental factors are related to melanoma pathogene-
sis. Risk factors are: history of sunburns and/or heavy 
sun exposure, blue or green eyes, blonde or red hair, 
fair complexion, numerous typical nevi and/or more 
than one atypical nevus, large congenital nevus, prior 
personal or family history of melanoma, germline 
mutations in the chromosome 9p21 tumor supresor 
gene, and somatic mutation in the BRAF gene (1).  
Understanding prognostic factors in cutaneous 
melanoma has evolved over the last decade, allowing 
oncologists to provide appropriate treatment. Many 
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of the prognostic factors are interrelated. For local-
ized primary melanoma, the dominant predictors 
of survival include lesion thickness, ulceration, and 
lymph node involvement. Factors such as age, sex, 
anatomic location, and satellite/in-transit lesions are 
important in localized melanoma (4). There is good 
prognostic correlation for the two micro-staging sys-
tems, Breslow depth and Clark level, commonly used 
to stage melanomas. Many investigators have report-
ed that Breslow depth is the superior microstaging 
method (5,6). Thickness remains the single most use-
ful variable. Prognosis declines more or less linearly 
with increasing thickness, modified by ulceration, mi-
totic rate, and other attributes (7). Tumors of greater 
Breslow depth are more likely to invade lymphatic or 
blood vessels allowing a route of passage for distant 
spread. Survival is accordingly shorter in such cases 
(8).
Due to the fact that there is no published data 
about melanoma in this region of Bosnia and Herze-
govina, the aim of our study was to determine clinical 
and morphological characteristics of primary mela-
noma since some of them are important prognostic 
factors. Some similar results have been published in a 
study in the western part of Herzegovina (10).
PatIentS and MethodS
This retrospective study included 172 patients 
with primary melanoma, 93 (54%) women and 79 
(46%) men. The data were collected by the Consult-
ing team for malignant skin tumors in Banja Luka 
Clinical Centre from 2009 to 2011. This team consists 
of an oncologist, dermatologist, pathologist, plastic 
and maxillofacial surgeons, and a specialist of nuclear 
medicine; the team examins patients with malignant 
skin tumors from all parts Republic of Srpska (the 
eastern part of Bosnia and Herzegovina). Consult-
ing team examination is the first step in the triage 
of patients with malignant skin tumors that are then 
referred for further diagnostic and therapeutic proce-
dures. The analysis included: sex, age, type and local-
ization of melanoma, Breslow thickness, lymph node 
involvement, and metastases. Type of melanoma was 
based on the classical division into nodular, superfi-
cial spreading, acral lentiginous, and lentigo maligna 
melanoma. Anatomical localization of the melanoma 
was divided into 5 groups: 1. head and neck, 2. front 
side of the trunk, 3. back, 4. hand and arm and 5. palm, 
sole, and finger. Mucosal melanomas were treated 
separately. Based on Breslow thickness patients with 
melanoma were divided into four groups. In the first 
group were patients with melanoma thickness less 
than 1.0 mm. Breslow thickness in second group was 
from 1.01 to 2.0 mm, and in third from 2.01 to 4.0 mm. 
Patients with melanoma thickness more than 4.01 
mm were in the fourth group. Based on melanoma 
spreading from primary localization, patients were 
also classified into four groups. Patients with macro 
and micro lymph node involvement were in the first 
group. Micro lymph node involvement was con-
firmed by sentinel lymph node biopsy. Patients with 
melanoma spreading to the soft tissue and distant 
metastases were in the second group. Patients with 
lung metastases were in the third group, and patients 
with other visceral metastases in the fourth group. 
StatIStICS
The SPSS software package (version 17.0) was 
used in this study. The data were analyzed by descrip-
tive and inferential statistical methods. Descriptive 
methods were used to analyze mean (X) and stan-
dard deviation (SD). Pearson χ2-test, Student’s t-test, 
and Kruskal Wallis test were used for inferential analy-
sis. A P value of <0.05 was considered statistically sig-
nificant. In cases when the study group had a small 
number of patients statistical significance was not 
calculated and was designated as not applicable. 
reSultS
The average age of our patients was 61 ± 14 years, 
63 ± 13 in men and in 59 females in women. The 











Nodular 47 ( 59.5) 25 (67.6) 22 (52.4) 0.662
Superficial spreading  22 (27.8) 8 ( 21.6) 14 (33.3) 0.201
Acral lentiginous 9 (11.4) 3 (8.1) 6 (14.3) NA*
Lentigo maligna 1 (1.3) 1 (2.7) - NA*
Total 79 (100) 37 (100) 42 (100) 0.574
*not applicable
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difference in average age between women and men 
was 4.4 years, which is statistically significant (t test; 
P=0.041). Melanoma was the most often diagnosed 
in patients in the sixth (27%) and seventh (25%) de-
cade of life. In women, melanoma was most often 
diagnosed in the sixth decade, and in men in the 
seventh decade of life. The difference was not statisti-
cally significant. The peak of incidence in both sexes 
was the 64th year.
Out of 172 patients, in 93 (54.1%) there was no 
data about the type of melanoma, and in 79 (46.0%) 
patients, there were data. The most common sub-
type was nodular melanoma in 59.5%, following su-
perficial spreading in 27.8%, and acral lentiginous 
melanoma in 11.4%. Only one patient had lentigo 
maligna melanoma. There was a statistically signifi-
cant difference (χ2-test, P<0.05) between the number 
of patients with nodular melanoma compared to the 
other sub-types of melanoma, but there was no sta-
tistically significant difference with regard to gender 
and sub-type of melanoma (Table 1).  
The most common localization of melanoma was 
on the back (34%), followed by the legs (19%), and 
arms and trunk (10%), while the rarest localization 
was on the palms, soles/fingers (5%). Bucal melano-
ma was diagnosed in 8 (5%) patients. The observed 
differences between the number of patients with 
melanoma on their back, legs, and head or neck were 
statistically significant (χ2-test, P< 0.05) compared to 
localized melanoma at other sites of the body. There 
was no statistically significant difference in the local-
ization of melanoma with regard to gender, except in 
patients with melanoma of the legs which was more 
common in females (Pearson χ2 test P< 0.05) (Table 
2).
Breslow thickness melanoma was known for 129 
(75%) patients; we lacked the data for the remaining 
25%. Median Breslow thickness was 4.6 mm. Breslow 
thickness over 4.0 mm was found in 38.0% patients, 
while only 6.2% patients had Breslow thickness less 
than 1.0 mm. In 55.8% patients Breslow thickness var-
ied from 1.0 to 4.0 mm. There was a statistically sig-
nificant difference between melanoma with Breslow 
thickness less than 1.0 mm and melanoma thicker 
than 1.0 mm both in the total sample and between 
men and women (χ2-test P<0.05). There was also a 
statistically significant difference (χ2-test; P<0.05) re-
garding gender for Breslow thickness a >4.0 mm, but 
there is no statistically significant difference regarding 
gender for other Breslow thickness values (Table 3).  
The thickest melanomas were localized on palms, 
soles, and fingers, the thinnest on the trunk. Using the 











Head/neck 28 (16.3) 12 (7.0) 16 (9.3) 0.450
Trunk (the front side) 18 (10.4) 9 (5.2) 9 (5.2) 1.000
Back 59 (34.3) 35 (20.3) 24 (14.0) 0.152
Hand/arm 18 (10.5) 8 (4.7) 10 (5.8) 0.637
Leg 32 (18.6) 6 (3.5) 26 (15.1) <0.05
Palm/sole/finger 9 (5.2) 3 (1.7) 6 (3.5) NA*
Mucosa 8 (4.7) 6 (3.5) 2 (1.2) NA*
Total 172 (100.0) 79 (45.9) 93 (54.1) 0.286
*not applicable
  table 3.  Breslow thickness of melanoma 
Sex








≤1.0 mm 8 (6.2) 2 (1.6) 6 (4.7) NA*
1.0-2.0 mm 33 (25.6) 14 (10.9) 19 (14.7) 0.384
2.0-4.0 mm 39 (30.2) 23 (17.8) 16 (12.4) 0.262
> 4,0  mm 49 (38.0) 16 (12.4) 33 (25.6) 0.015
Total 129 (100.0) 55 (42.6) 74 (57.4) 0.286
*not applicable
Balaban et al. Acta Dermatovenerol Croat
Characteristics of cutaneous melanoma       2014;22(4):271-277
274 ACTA DERMATOVENEROLOGICA CROATICA
Kruskal Wallis test we found no statistically significant 
difference (P=0.546) in Breslow thickness regarding 
anatomical localization of melanoma.
Out of 172 patients, in almost one third (31.4%) 
we determined spreading of melanoma out of pri-
mary skin localization, more frequently in men than 
in women (χ2-test, P<0.05). Most commonly involved 
were the lymph nodes (66.6%, χ2-test, P<0.05). Less 
common was spreading involing soft tissue and dis-
tant nodal metastasis (16.7%), and other visceral me-
tastases (12.9%). Only one patient had lung metasta-
sis. Using χ2-test we found no statistically significant 
difference regarding gender and lymph node involve-
ment (P=0.499). Due to the small number of patients 
with other metastasis sites, statistical significance is 
not applicable (Table 4).
dISCuSSIon
The main findings of our research are that cuta-
neous melanoma usually occurs in elderly patients as 
a nodular sub-type, and that the tumor is diagnosed 
late because the average Breslow thickness is 4.6 
mm. 
In our study, melanoma was equally common in 
women and men. This is in contrast with the study by 
Brady et al. in which men are more likely than women 
to develop melanoma (67% higher incidence) (11). 
From the GLOBOCAN 2008 estimates all Western Eu-
ropean countries, with the exception of Austria, have 
higher incidence rates for women than for men, and 
the same trend is apparent for most Northern Europe-
an countries. In contrast, for most of Central, Eastern, 
and Southern Europe, incidence rates are higher in 
men. Melanoma mortality is higher in men compared 
with women throughout Europe (2). The average age 
of our patients with melanoma is 61 years. It is almost 
a decade more than in the data of Paek et al. in which 
the mean age of diagnosis was relatively young (at 
52 years), and more than 25% of melanomas occured 
in persons younger than 45 years, but it is in accor-
dance with the data from Croatia, where the greatest 
increase of melanoma incidence rates was in 60-year-
old males (1,12). Melanoma statistics data reported 
the median age at diagnosis was between 45 and 
55. Weih et al. concluded that invasive melanoma of 
the skin is the third most common cancer diagnosed 
among adolescents and young adults (aged 15-39 
years) in the United States (13,14). However, our data 
are consistent with the results of the U.S. National 
Cancer Institute, which states that the median age at 
diagnosis for melanoma of the skin was 61 years of 
age (15). Our male patients were older than females. 
The average age in men was 63, and in woman 59, 
which is also in accordance with data from the United 
States where after age of 40 the men have a higher 
incidence rate and the difference becomes remark-
ably large with increasing age (1). We found that pa-
tients most often (60%) had nodular and superficial 
spreading (28%) sub-types of melanoma. This result 
is in contrast with data available from the literature. It 
is known that superficial spreading melanoma is the 
most common, and nodular is the second most com-
mon melanoma sub-type (9). The frequency of super-
ficial spreading melanoma in the literature is about 
64-70%, and about 14-30% for nodular melanoma. 
Many studies confirm this fact (1,3,10,16-18). Only 
9% of our patients had acral lentiginous melanoma. 
This sub-type occurs less frequently in the literature 
as well. Although rare, it is potentially dangerous and 
has a poor prognosis compared with melanoma at 
other sites, which requiring specific management 











Total spreading 54 (31.4) 32 (40.5) 22 (23.6) 0.027
Lymph nodes involvement 36 (66.7) 21 (65.7) 15 (68.2) 0.499
Soft tissue/ Distant nodal 
metastasis 9 (16.7) 6 (18.8) 3 (13.7) NA*
Lung metastasis 2 (3.7) 2 (6.2) - NA*
Other visceral metastasis 7 (12.9) 3 (9.3) 4 (18.1) NA*
Patients without metastasis 118 (68.6) 47 (55.5) 71 (77.4) 0.027
Total patients 172 (100.0) 79 (45.9) 93 (54.1) 0.286
*not applicable
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from their prevention up to their treatment (19). The 
most common locations of melanoma in our study 
were the trunk (44.7%), legs (18.6%), and head/neck 
(16.3%). Several studies throughout the world have 
identified differences in the anatomic distribution 
of melanomas in men when compared with women 
(2,4). When it comes to anatomical localization, our 
results are similar to other countries in Europe and 
worldwide since the trunk and lower limbs appear 
to be the most frequent sites of melanoma (20). Simi-
lar to other countries, in our population melanomas 
were predominantly located on the trunk in men and 
on the lower limbs in women. Gender differences 
in body site distribution of melanoma lesions have 
been thought to be a result of inherent differences 
between men and women. Differences in clothing, 
hair style, occupation, sun-seeking behavior, preven-
tive measures, and seeking medical care have all been 
considered as potential reasons for the higher inci-
dence of lesions on the lower extremities in women 
and lesions of the head, neck, and trunk areas of the 
body in men. However, the reasons for the observed 
gender differences may go beyond societal differ-
ences among males and females, and depend on the 
relationship between steroid hormones (21). The ana-
tomic location of the primary melanoma is an impor-
tant independent predictor of sentinel lymph node 
status and prognosis. Patients with primary melano-
mas of the head/neck and trunk have a worse prog-
nosis than those with primary melanomas on other 
anatomic locations (22). In our patients, melanomas 
were diagnosed in their later stages because the av-
erage Breslow thickness of melanomas was 4.6 mm. 
Thin melanomas (under 1.0 mm) were present only 
in 6.2% patients, whereas 55.8% had melanoma 1.0-
4.0 mm thick, and 38% had melanoma thicker than 
4.0 mm. A group of authors from the Mayo Clinic was 
exploring the association of socioeconomic status of 
patients with Breslow thickness and came to the con-
clusion that low socioeconomic status is associated 
with thicker melanoma and a poorer clinical outcome 
(23). It is known that Bosnia and Herzegovina is one of 
the countries with the lowest socioeconomic status in 
Europe. Poor socioeconomic status and the older age 
of our patients are probably the two most important 
reasons for having such thick melanomas. Similar 
results were found by Polish authors. In their study, 
in the ≥65 years group the median Breslow thick-
ness was 5.0 mm (24). In Bulgaria and Romania, for 
instance, an estimated 25% of patients present with 
stage III and IV disease, while thin melanomas under 
1.0 mm make for less than 10% of newly diagnosed 
cases. High rates of advanced-stage melanomas have 
been reported in the Russian Federation, and a me-
dian tumor thickness of 4.0 mm has been reported 
in Serbia. This is in sharp contrast to Western Europe, 
where up to 70% of newly diagnosed melanomas are 
<1 mm thick (2). However, some studies confirm that 
in rural parts of Western Europe mean Breslow thick-
ness was much higher than previously observed in 
other regions in Western Europe (25). Our female pa-
tients tend to have melanoma of more than 4.0 mm 
more commonly than male patients (P<0.05), while 
for the other thickness there were no differences be-
tween men and women. These results are contrary to 
the finding of German authors, where male patients 
had significantly thicker melanoma (26). Anatomic lo-
cations included the head/neck and trunk, and age 
and Breslow thickness are an important independent 
predictors of sentinel lymph node status and prog-
nosis (22). As in 61% of our patients, melanoma was 
localized on the head, neck and trunk, the average 
Breslow thickness was 4.6 mm, and those patients 
were elderly, which may be a reasons that almost 
one third (31.4%) of our patients had tumor spread 
beyond the primary location. In most cases (20.9%), 
there was regional macroscopic and microscopic 
lymph node involvement. Regarding age, our results 
confirms the conclusion of the American authors that 
higher incidence of local/in-transit metastases is seen 
among the elderly (27). In our study, lymph node in-
volvement was greater in men than in women. In a 
study on a large number of patients in Germany, it 
was concluded that men had higher probability for 
developing metastases and distant metastases after 
diagnosis of a primary tumor. Additionally, if disease 
progression took place, women developed their first 
metastasis as well as distant metastasis significantly 
later compared with men. When the metastatic path-
ways are taken into consideration, women were more 
frequently first to progress to local sites in the form of 
satellite or in-transit metastases, and men more fre-
quently exhibited direct regional lymph node metas-
tasis. About two thirds of these patients, more men 
than women, showed further progression to distant 
sites (29).
ConCluSIon
We found that cutaneous melanoma occurs 
equally commonly in both sexes, in women in the 
sixth decade of life and the seventh in men. The most 
common sub-type was nodular melanoma. The most 
common localization was on the back in men and on 
the legs in woman. Melanoma among our patients 
was detected late since the average Breslow thick-
ness was 4.6 mm, and nearly every third patient had 
spread beyond the primary tumor localization. We 
are aware that our study has some limitations. In our 
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investigation we did not use dermoscopy as a diag-
nostic tool. Our sample was small, and in a number 
of patients are missing all the relevant data, but we 
wanted to show that we found high incidence of dan-
gerous thick melanomas, which indicates the need for 
a better unique regional registry in this part of Bosnia 
and Herzegovina and improved preventive measures 
in the early diagnosis of melanoma. 
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